Advertisement
Right ventricular dilation is associated with in-hospital mortality among patients hospitalized with COVID-19

Right Ventricular Dilation Linked to Mortality in COVID-19

0
Right ventricular enlargement significantly linked to in-hospital mortality in multivariable analysis
A recombinant adenovirus type-5 vectored COVID-19 vaccine is safe

Adenovirus Type-5 Vectored COVID-19 Vaccine Shows Promise

0
ELISA antibodies and neutralizing antibodies increased at day 14, peaked at day 28
For patients with COVID-19 requiring hospitalization

Hydroxychloroquine Plus Macrolides No Benefit in COVID-19

0
Hydroxychloroquine, chloroquine with or without macrolides linked to in-hospital mortality, arrhythmia
For adults hospitalized with COVID-19 with lower respiratory tract infection

Remdesivir Beats Placebo for Time to COVID-19 Recovery

0
Researchers suggest antiviral agents in combination with other therapeutic approaches may further improve outcomes
The World Health Organization has suspended use of the antimalarial drug hydroxychloroquine in a clinical trial of treatments of COVID-19 after a study revealed that patients taking the drug are at increased risk for death and serious heart problems.

WHO Suspends Testing of Hydroxychloroquine in COVID-19 Patients

0
In light of recent findings, hydroxychloroquine arm of WHO global study paused temporarily
Daily use of a fine particulate matter air filtration device can significantly improve airway mechanics and reduce airway resistance in children with asthma

Air Filters Shown to Improve Breathing in Children With Asthma

0
Daily in-bedroom use of a PM2.5 filter results in significant improvement of airway mechanics
A chest X-ray severity score can predict outcomes among young and middle-aged adults with COVID-19 on presentation to the emergency department

ED Chest X-Ray Score Predicts COVID-19 Outcomes in Adults <50

0
CXR severity score ≥2 and obesity independent predictors of hospital admission
The U.S. Department of Health and Human Services said Thursday it would provide up to $1.2 billion to AstraZeneca to develop a potential COVID-19 vaccine from a lab in Oxford

U.S. Offers $1.2 Billion to Drug Company for COVID-19 Vaccine Research

0
Deal will fund phase 3 clinical trial in the United States this summer with about 30,000 volunteers
Older age

Age, Sex, History of Diabetes Predict Intubation in COVID-19

0
Only factors independently associated with time to extubation are age and body mass index
Here is what the editors at Physician's Briefing chose as the most important COVID-19 developments for you and your practice for the week of May 18 to 22

Physician’s Briefing Weekly Coronavirus Roundup

0
Here is what the editors at Physician's Briefing chose as the most important COVID-19 developments for you and your practice for the week of...